SyntekaBio, Inc. (KOSDAQ:226330)
South Korea · Delayed Price · Currency is KRW 4,130.00
-20.00 (-0.48%)
At close: Oct 2, 2025
SyntekaBio Revenue
SyntekaBio had revenue of 345.91M KRW in the quarter ending June 30, 2025, with 38,335.95% growth. This brings the company's revenue in the last twelve months to 1.33B, up 968.07% year-over-year. In the year 2024, SyntekaBio had annual revenue of 120.89M, down -2.04%.
Revenue (ttm)
1.33B
Revenue Growth
+968.07%
P/S Ratio
46.52
Revenue / Employee
n/a
Employees
n/a
Market Cap
61.80B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 120.89M | -2.52M | -2.04% |
| Dec 31, 2023 | 123.41M | -120.59M | -49.42% |
| Dec 31, 2022 | 243.99M | -72.67M | -22.95% |
| Dec 31, 2021 | 316.66M | -293.02M | -48.06% |
| Dec 31, 2020 | 609.68M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 308.59T |
| SK hynix | 77.21T |
| LG Energy Solution | 25.16T |
| Samsung Biologics | 5,031.69B |
| Hanwha Aerospace | 19.25T |
| Doosan Enerbility | 16.30T |
| Hyundai Motor Company | 182.25T |
| HD Hyundai Heavy Industries | 15.58T |